These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 30341284)

  • 1. Activation of the interferon type I response rather than autophagy contributes to myogenesis inhibition in congenital DM1 myoblasts.
    Rizzo M; Beffy P; Del Carratore R; Falleni A; Pretini V; D'Aurizio R; Botta A; Evangelista M; Stoccoro A; Coppedè F; Furling D; Simili M
    Cell Death Dis; 2018 Oct; 9(11):1071. PubMed ID: 30341284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered signal transduction pathways and induction of autophagy in human myotonic dystrophy type 1 myoblasts.
    Beffy P; Del Carratore R; Masini M; Furling D; Puymirat J; Masiello P; Simili M
    Int J Biochem Cell Biol; 2010 Dec; 42(12):1973-83. PubMed ID: 20797447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recovery in the Myogenic Program of Congenital Myotonic Dystrophy Myoblasts after Excision of the Expanded (CTG)
    André LM; van Cruchten RTP; Willemse M; Bezstarosti K; Demmers JAA; van Agtmaal EL; Wansink DG; Wieringa B
    Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31766224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MyoD transcription factor induces myogenesis by inhibiting Twist-1 through miR-206.
    Koutalianos D; Koutsoulidou A; Mastroyiannopoulos NP; Furling D; Phylactou LA
    J Cell Sci; 2015 Oct; 128(19):3631-45. PubMed ID: 26272918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immortalized human myotonic dystrophy muscle cell lines to assess therapeutic compounds.
    Arandel L; Polay Espinoza M; Matloka M; Bazinet A; De Dea Diniz D; Naouar N; Rau F; Jollet A; Edom-Vovard F; Mamchaoui K; Tarnopolsky M; Puymirat J; Battail C; Boland A; Deleuze JF; Mouly V; Klein AF; Furling D
    Dis Model Mech; 2017 Apr; 10(4):487-497. PubMed ID: 28188264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long non-coding RNA Irm enhances myogenic differentiation by interacting with MEF2D.
    Sui Y; Han Y; Zhao X; Li D; Li G
    Cell Death Dis; 2019 Feb; 10(3):181. PubMed ID: 30792383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MyoD and myogenin expression patterns in cultures of fetal and adult chicken myoblasts.
    Yablonka-Reuveni Z; Paterson BM
    J Histochem Cytochem; 2001 Apr; 49(4):455-62. PubMed ID: 11259448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutant DMPK 3'-UTR transcripts disrupt C2C12 myogenic differentiation by compromising MyoD.
    Amack JD; Reagan SR; Mahadevan MS
    J Cell Biol; 2002 Nov; 159(3):419-29. PubMed ID: 12427866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MUNC, a long noncoding RNA that facilitates the function of MyoD in skeletal myogenesis.
    Mueller AC; Cichewicz MA; Dey BK; Layer R; Reon BJ; Gagan JR; Dutta A
    Mol Cell Biol; 2015 Feb; 35(3):498-513. PubMed ID: 25403490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor necrosis factor-alpha inhibits myogenic differentiation through MyoD protein destabilization.
    Langen RC; Van Der Velden JL; Schols AM; Kelders MC; Wouters EF; Janssen-Heininger YM
    FASEB J; 2004 Feb; 18(2):227-37. PubMed ID: 14769817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. S100B protein in myoblasts modulates myogenic differentiation via NF-kappaB-dependent inhibition of MyoD expression.
    Tubaro C; Arcuri C; Giambanco I; Donato R
    J Cell Physiol; 2010 Apr; 223(1):270-82. PubMed ID: 20069545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glutathione depletion impairs myogenic differentiation of murine skeletal muscle C2C12 cells through sustained NF-kappaB activation.
    Ardite E; Barbera JA; Roca J; Fernández-Checa JC
    Am J Pathol; 2004 Sep; 165(3):719-28. PubMed ID: 15331397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased levels of myotonic dystrophy protein kinase (DMPK) and delayed differentiation in human myotonic dystrophy myoblasts.
    Furling D; Lemieux D; Taneja K; Puymirat J
    Neuromuscul Disord; 2001 Nov; 11(8):728-35. PubMed ID: 11595515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficient CRISPR/Cas9-mediated editing of trinucleotide repeat expansion in myotonic dystrophy patient-derived iPS and myogenic cells.
    Dastidar S; Ardui S; Singh K; Majumdar D; Nair N; Fu Y; Reyon D; Samara E; Gerli MFM; Klein AF; De Schrijver W; Tipanee J; Seneca S; Tulalamba W; Wang H; Chai YC; In't Veld P; Furling D; Tedesco FS; Vermeesch JR; Joung JK; Chuah MK; VandenDriessche T
    Nucleic Acids Res; 2018 Sep; 46(16):8275-8298. PubMed ID: 29947794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deltex2 represses MyoD expression and inhibits myogenic differentiation by acting as a negative regulator of Jmjd1c.
    Luo D; de Morree A; Boutet S; Quach N; Natu V; Rustagi A; Rando TA
    Proc Natl Acad Sci U S A; 2017 Apr; 114(15):E3071-E3080. PubMed ID: 28351977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of age upon the expression of three miRNAs in muscle stem cells isolated from two different porcine skeletal muscles.
    Redshaw Z; Sweetman D; Loughna PT
    Differentiation; 2014; 88(4-5):117-23. PubMed ID: 25542334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional KCa1.1 channels are crucial for regulating the proliferation, migration and differentiation of human primary skeletal myoblasts.
    Tajhya RB; Hu X; Tanner MR; Huq R; Kongchan N; Neilson JR; Rodney GG; Horrigan FT; Timchenko LT; Beeton C
    Cell Death Dis; 2016 Oct; 7(10):e2426. PubMed ID: 27763639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recapitulating muscle disease phenotypes with myotonic dystrophy 1 induced pluripotent stem cells: a tool for disease modeling and drug discovery.
    Mondragon-Gonzalez R; Perlingeiro RCR
    Dis Model Mech; 2018 Jul; 11(7):. PubMed ID: 29898953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The RNA-binding protein Rbm24 is transiently expressed in myoblasts and is required for myogenic differentiation during vertebrate development.
    Grifone R; Xie X; Bourgeois A; Saquet A; Duprez D; Shi DL
    Mech Dev; 2014 Nov; 134():1-15. PubMed ID: 25217815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. v-Src inhibits myogenic differentiation by interfering with the regulatory network of muscle-specific transcriptional activators at multiple levels.
    Falcone G; Ciuffini L; Gauzzi MC; Provenzano C; Strano S; Gallo R; Castellani L; Alemà S
    Oncogene; 2003 Nov; 22(51):8302-15. PubMed ID: 14614454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.